Bill > HB07022

This bill aims to expand Medicaid coverage for fertility-related healthcare by requiring the Commissioner of Social Services to amend the state Medicaid plan to provide coverage for fertility diagnostic care, fertility preservation services, and fertility treatment. The bill comprehensively defines key terms such as "infertility" (which includes medical conditions affecting fertility, inability to achieve pregnancy after specific timeframes, and genetic risks), "fertility diagnostic care" (procedures and services to assess fertility), "fertility preservation services" (procedures to preserve fertility for individuals with medical conditions), and "fertility treatment" (medical procedures intended to achieve a live birth). Specifically, the bill mandates coverage for medically necessary ovulation-enhancing drugs and related medical services, including at least three cycles of ovulation-enhancing medication treatment. Additionally, the bill requires the Commissioner to submit a report by July 1, 2026, exploring the potential for adding in-vitro fertilization as a covered benefit, including potential Medicaid waivers and estimated state funding requirements. The provisions are set to take effect on January 1, 2026, and are designed to provide more comprehensive reproductive healthcare support for Medicaid recipients.